Accordingly, this research aimed to address and underscore the role of IL-13, as well as its receptors and some of the signaling genes and integrated crosstalk genes, in the prediction of advanced fibrosis progression and HCC development in NASH. Here, IL13 is linked to metabolic dysfunction-associated steatohepatitis.